Skip to content

Clinical trials

Phase 2 Prostatic Neoplasms, Castration-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms, Castration-Resistant Phase: Phase 2 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20183
20191
20212
20224
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Completed3
Recruiting3
Active, not recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC2
MacroGenics2
Australian and New Zealand Urogenital and Prostate Cancer Trials Group1
Bayer1
Bristol-Myers Squibb1
British Columbia Cancer Agency1
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic1
Leiden University Medical Center1
Novartis Pharmaceuticals1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms, Castration-Resistant16
Prostatic Neoplasms5
Anus Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Small Cell1
Melanoma1
Neoplasm Metastasis1
Neoplasms1
Small Cell Lung Carcinoma1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.